AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
PANTOPRAZOLE DOES NOT AFFECT PERFORMANCE IN TRAFFIC-RELATED SAFETY TESTS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER STUDY IN HEALTHY-VOLUNTEERS
Authors: HERBERG KW HARTMANN M NEUKIRCHEN B LUHMANN R THOMAS KB WURST W
Citation: Kw. Herberg et al., PANTOPRAZOLE DOES NOT AFFECT PERFORMANCE IN TRAFFIC-RELATED SAFETY TESTS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER STUDY IN HEALTHY-VOLUNTEERS, Clinical drug investigation, 16(1), 1998, pp. 63-70
PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS WITH END-STAGE RENAL-FAILURE
Authors: KLIEM V BAHLMANN J HARTMANN M HUBER R LUHMANN R WURST W
Citation: V. Kliem et al., PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS WITH END-STAGE RENAL-FAILURE, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1189-1193
PANTOPRAZOLE 20 MG IS EFFECTIVE FOR RELIEF OF SYMPTOMS AND HEALING OFLESIONS IN MILD REFLUX ESOPHAGITIS
Authors: DETTMER A VOGT R SIELAFF F LUHMANN R SCHNEIDER A FISCHER R
Citation: A. Dettmer et al., PANTOPRAZOLE 20 MG IS EFFECTIVE FOR RELIEF OF SYMPTOMS AND HEALING OFLESIONS IN MILD REFLUX ESOPHAGITIS, Alimentary pharmacology & therapeutics, 12(9), 1998, pp. 865-872
EQUIPOTENT INHIBITION OF GASTRIC-ACID SECRETION BY EQUAL DOSES OF ORAL OR INTRAVENOUS PANTOPRAZOLE
Authors: HARTMANN M EHRLICH A FUDER H LUHMANN R EMEKLIBAS S TIMMER W WURST W LUCKER PW
Citation: M. Hartmann et al., EQUIPOTENT INHIBITION OF GASTRIC-ACID SECRETION BY EQUAL DOSES OF ORAL OR INTRAVENOUS PANTOPRAZOLE, Alimentary pharmacology & therapeutics, 12(10), 1998, pp. 1027-1032
PANTOPRAZOLE IN PATIENTS WITH VARYING DEGREE OF LIVER IMPAIRMENT IN COMPARISON TO HEALTHY CONTROLS
Authors: BREUEL HP HORAK J HOREJSOVA M HEINE PR HARTMANN M HUBER R LUHMANN R WURST W
Citation: Hp. Breuel et al., PANTOPRAZOLE IN PATIENTS WITH VARYING DEGREE OF LIVER IMPAIRMENT IN COMPARISON TO HEALTHY CONTROLS, Gastroenterology, 114(4), 1998, pp. 19-19
COMPARISON OF PANTOPRAZOLE 20 MG TWICE-DAILY WITH 40 MG ONCE-DAILY ONINTRAGASTRIC PH IN HEALTHY-VOLUNTEERS
Authors: MONNIKES H WEBER S TEBBE J LUHMANN R FISCHER R ARNOLD R KOOP H
Citation: H. Monnikes et al., COMPARISON OF PANTOPRAZOLE 20 MG TWICE-DAILY WITH 40 MG ONCE-DAILY ONINTRAGASTRIC PH IN HEALTHY-VOLUNTEERS, Gastroenterology, 114(4), 1998, pp. 950-950
THE REVERSIBLE H-ATPASE-ANTAGONIST BY 841 IS MORE EFFECTIVE IN ELEVATING GASTRIC PH IN HELICOBACTER-PYLORI POSITIVE THAN IN HP-NEGATIVE VOLUNTEERS(,K+)
Authors: RIEDEL T HARTMANN M LUHMANN R WURST W SCHEPP W
Citation: T. Riedel et al., THE REVERSIBLE H-ATPASE-ANTAGONIST BY 841 IS MORE EFFECTIVE IN ELEVATING GASTRIC PH IN HELICOBACTER-PYLORI POSITIVE THAN IN HP-NEGATIVE VOLUNTEERS(,K+), Gastroenterology, 114(4), 1998, pp. 1101-1101
MORNING AND EVENING ADMINISTRATION OF PANTOPRAZOLE - A STUDY TO COMPARE THE EFFECT ON 24-HOUR INTRAGASTRIC PH
Authors: MUSSIG S WITZEL L LUHMANN R SCHNEIDER A
Citation: S. Mussig et al., MORNING AND EVENING ADMINISTRATION OF PANTOPRAZOLE - A STUDY TO COMPARE THE EFFECT ON 24-HOUR INTRAGASTRIC PH, European journal of gastroenterology & hepatology, 9(6), 1997, pp. 599-602
PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION
Authors: FUDER H HARTMANN M WIECKHORST G EHRLICH A TIMMER W LUHMANN R WURST W
Citation: H. Fuder et al., PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION, Gut, 41, 1997, pp. 97-97
THE EFFECT OF INTRAVENOUS PANTOPRAZOLE IS ENHANCED BY PENTAGASTRIN
Authors: STRAATHOF JWA GIELKENS HAJ WURST W HARTMANN M LUHMANN R LAMERS CBHW MASCLEE AAM
Citation: Jwa. Straathof et al., THE EFFECT OF INTRAVENOUS PANTOPRAZOLE IS ENHANCED BY PENTAGASTRIN, Gut, 41, 1997, pp. 97-97
INTRAGASTRIC PH IN PATIENTS WITH BLEEDING PEPTIC-ULCERATION DURING PANTOPRAZOLE INFUSION OF 8 MG HOUR/
Authors: VANRENSBURG CJ THORPE A WARREN B VENTER JL THERON I HARTMANN M LUHMANN R WURST W
Citation: Cj. Vanrensburg et al., INTRAGASTRIC PH IN PATIENTS WITH BLEEDING PEPTIC-ULCERATION DURING PANTOPRAZOLE INFUSION OF 8 MG HOUR/, Gut, 41, 1997, pp. 98-98
EFFECT OF A 28 DAY THERAPY WITH THE ACID PUMP ANTAGONIST BY841 AND WITH THE H2-RECEPTOR ANTAGONIST RANITIDINE ON INTRAGASTRIC PH IN HEALTHY-HUMAN SUBJECTS
Authors: TEYSSEN S PFUTZER R KOLLE J HARDER H STEPHAN F HARTMANN M LUHMANN R WURST W SINGER MV
Citation: S. Teyssen et al., EFFECT OF A 28 DAY THERAPY WITH THE ACID PUMP ANTAGONIST BY841 AND WITH THE H2-RECEPTOR ANTAGONIST RANITIDINE ON INTRAGASTRIC PH IN HEALTHY-HUMAN SUBJECTS, Gut, 41, 1997, pp. 99-99
PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION
Authors: FUDER H HARTMANN M WIECKHORST G EHRLICH A TIMMER W LUHMANN R WURST W
Citation: H. Fuder et al., PANTOPRAZOLE IS EQUIPOTENT AFTER ORAL INTAKE AND INTRAVENOUS ADMINISTRATION, Gastroenterology, 112(4), 1997, pp. 119-119
COMPARISON OF THE EFFECT OF A 28 DAY THERAPY WITH THE ACID PUMP ANTAGONIST BY841 WITH THE H2-RECEPTOR ANTAGONIST RANITIDINE ON INTRAGASTRICPH IN HEALTHY-HUMAN SUBJECTS
Authors: PFUTZER R TEYSSEN S KOLLE J HARDER H STEPHAN F HARTMANN M LUHMANN R WURST W SINGER MV
Citation: R. Pfutzer et al., COMPARISON OF THE EFFECT OF A 28 DAY THERAPY WITH THE ACID PUMP ANTAGONIST BY841 WITH THE H2-RECEPTOR ANTAGONIST RANITIDINE ON INTRAGASTRICPH IN HEALTHY-HUMAN SUBJECTS, Gastroenterology, 112(4), 1997, pp. 258-258
PENTAGASTRIN ENHANCES THE EFFECT OF INTRAVENOUS PANTOPRAZOLE
Authors: STRAATHOF JWA GIELKENS HAJ WURST W HARTMANN M LUHMANN R LAMERS CBHW MASCLEE AAM
Citation: Jwa. Straathof et al., PENTAGASTRIN ENHANCES THE EFFECT OF INTRAVENOUS PANTOPRAZOLE, Gastroenterology, 112(4), 1997, pp. 299-299
INTRAGASTRIC PH IN PATIENTS WITH BLEEDING PEPTIC-ULCERATION DURING PANTOPRAZOLE INFUSION OF 8 MG HOUR/
Authors: VANRENSBURG CJ THORPE A WARREN B VENTER JL THERON I HARTMANN M LUHMANN R WURST W
Citation: Cj. Vanrensburg et al., INTRAGASTRIC PH IN PATIENTS WITH BLEEDING PEPTIC-ULCERATION DURING PANTOPRAZOLE INFUSION OF 8 MG HOUR/, Gastroenterology, 112(4), 1997, pp. 321-321
INTRAGASTRIC PH AND SERUM GASTRIN DURING ADMINISTRATION OF DIFFERENT DOSES OF PANTOPRAZOLE IN HEALTHY-SUBJECTS
Authors: KOOP H KULY S FLUG M EISSELE R MONNIKES H ROSE K LUHMANN R SCHNEIDER A FISCHER R ARNOLD R
Citation: H. Koop et al., INTRAGASTRIC PH AND SERUM GASTRIN DURING ADMINISTRATION OF DIFFERENT DOSES OF PANTOPRAZOLE IN HEALTHY-SUBJECTS, European journal of gastroenterology & hepatology, 8(9), 1996, pp. 915-918
PHARMACOKINETICS OF PANTOPRAZOLE IN MAN
Authors: HUBER R HARTMANN M BLIESATH H LUHMANN R STEINIJANS VW ZECH K
Citation: R. Huber et al., PHARMACOKINETICS OF PANTOPRAZOLE IN MAN, International journal of clinical pharmacology and therapeutics, 34(5), 1996, pp. 185-194
PHARMACOKINETICS OF PANTOPRAZOLE IN MAN
Authors: HUBER R HARTMANN M BLIESATH H LUHMANN R STEINIJANS VW ZECH K
Citation: R. Huber et al., PHARMACOKINETICS OF PANTOPRAZOLE IN MAN, International journal of clinical pharmacology and therapeutics, 34, 1996, pp. 7-16
DOSE LINEARITY OF THE PHARMACOKINETICS OF THE NEW H+ K+-ATPASE INHIBITOR PANTOPRAZOLE AFTER SINGLE INTRAVENOUS ADMINISTRATION/
Authors: BLIESATH H HUBER R HARTMANN M LUHMANN R WURST W
Citation: H. Bliesath et al., DOSE LINEARITY OF THE PHARMACOKINETICS OF THE NEW H+ K+-ATPASE INHIBITOR PANTOPRAZOLE AFTER SINGLE INTRAVENOUS ADMINISTRATION/, International journal of clinical pharmacology and therapeutics, 34, 1996, pp. 18-24
24-HOUR INTRAGASTRIC PH PROFILES AND PHARMACOKINETICS FOLLOWING SINGLE AND REPEATED ORAL-ADMINISTRATION OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN COMPARISON TO OMEPRAZOLE
Authors: HARTMANN M THEISS U HUBER R LUHMANN R BLIESATH H WURST W LUCKER PW
Citation: M. Hartmann et al., 24-HOUR INTRAGASTRIC PH PROFILES AND PHARMACOKINETICS FOLLOWING SINGLE AND REPEATED ORAL-ADMINISTRATION OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN COMPARISON TO OMEPRAZOLE, Alimentary pharmacology & therapeutics, 10(3), 1996, pp. 359-366
COMPARATIVE TRIAL OF PANTOPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX ESOPHAGITIS - RESULTS OF A GERMAN MULTICENTER STUDY
Authors: KOOP H SCHEPP W DAMMANN HG SCHNEIDER A LUHMANN R CLASSEN M
Citation: H. Koop et al., COMPARATIVE TRIAL OF PANTOPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX ESOPHAGITIS - RESULTS OF A GERMAN MULTICENTER STUDY, Journal of clinical gastroenterology, 20(3), 1995, pp. 192-195
PHARMACOKINETICS OF PANTOPRAZOLE IN HEMODIALYSIS-PATIENTS
Authors: KLIEM V HARTMANN M HUBER R LUHMANN R BLIESATH H WURST W BAHLMANN J
Citation: V. Kliem et al., PHARMACOKINETICS OF PANTOPRAZOLE IN HEMODIALYSIS-PATIENTS, Kidney international, 47(3), 1995, pp. 984-984
1ST ADMINISTRATION TO MAN OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR-BY841 - TOLERABILITY, SAFETY AND PH-METRY
Authors: FUDER H HARTMANN M TIMMER W LUHMANN R WIECKHORST G HUBER R BLIESATH H WURST W POSTIUS S RADTKE HW LUCKER PW
Citation: H. Fuder et al., 1ST ADMINISTRATION TO MAN OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR-BY841 - TOLERABILITY, SAFETY AND PH-METRY, Gastroenterology, 108(4), 1995, pp. 96-96
SAFETY, TOLERABILITY AND EFFECT ON PENTAGASTRIN-STIMULATED GASTRIC-ACID OUTPUT (PSAO) OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR BY841
Authors: SIMON B MULLER P HARTMANN M HUBER R BLIESATH H LUHMANN R WURST W RADTKE HW
Citation: B. Simon et al., SAFETY, TOLERABILITY AND EFFECT ON PENTAGASTRIN-STIMULATED GASTRIC-ACID OUTPUT (PSAO) OF THE NEW REVERSIBLE PROTON PUMP INHIBITOR BY841, Gastroenterology, 108(4), 1995, pp. 220-220
Risultati: 1-25 | 26-29